• SENSEX
    NIFTY 50
Healthcare

Dr Reddy's gets 8 observations from USFDA for its Duvvada facility

Updated : August 21, 2019 08:49 AM IST

The audit of the company's formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the United States Food and Drug Administration (USFDA) completed on Tuesday, Dr. Reddy's said in a filing to the BSE.
The FDA Form 483 notifies the company's management of objectionable conditions.
Dr Reddy's gets 8 observations from USFDA for its Duvvada facility

You May Also Like

Live TV

recommended for you

Advertisement